glp-1 meds Agonists: A Comprehensive Overview GLP-1s for Weight Loss: What

Results The first cohort included 36082 GLP-1 receptor agonist users (median follow-up 1.3 years) and 234028 DPP-4 inhibitor users (median follow-up 1.7 years)

Supports a balanced gut microbiome*

Jardiance (empagliflozin) 38% CV death reduction vs Mounjaro (tirzepatide) 21% weight loss (EMPA-REG vs SURPASS)

others seek natural alternatives to the prescriptions

Supresa Saffron Extract: Standardized to 0.3% safranal, this extract has been associated with a 69% decrease in hunger and a 55% reduction in snacking events over an eight-week period

Formulated to help you stay in control of cravings, feel fuller for longer, and maintain balanced eating habits ideal for long-term weight-management goals for women and men